Abstract:Microencapsulation is a promising strategy to prolong the survival and function of transplanted pancreatic islets for diabetes therapy, albeit its translation has been impeded by incoherent graft performance. The use of decellularized ECM has lately gained substantial research momentum due to its innate capacity to augment the function of cells originating from the same tissue type. In the present study, the advantages of both these approaches are leveraged in a porcine pancreatic ECM (pECM)-based microencapsulation platform, thus significantly enhancing murine pancreatic islet performance. pECM-encapsulated islets sustain high insulin secretion levels in vitro, surpassing those of islets encapsulated in conventional alginate microcapsules. Moreover, pECM-encapsulated islet cells proliferate and produce an enriched intra-islet ECM framework, displaying a distinctive structural rearrangement. The beneficial effect of pECM encapsulation is further reinforced by the temporary protection against cytokine-induced cytotoxicity. In-vivo, this platform significantly improves glucose tolerance and achieves glycemic correction in 100% of immunocompetent diabetic mice without any immunosuppression, compared to only 50% mice achieved glycemic correction by alginate encapsulation. Altogether, the results presented herein reveal that pECM-based microencapsulation offers a natural pancreatic niche that can restore the function of isolated pancreatic islets and deliver them safely, avoiding the need for immunosuppression. STATEMENT OF SIGNIFICANCE: Aiming to improve pancreatic islet transplantation outcomes in diabetic patients, we developed a microencapsulation platform based on pancreatic extracellular matrix (pECM). In these microcapsules the islets are entrapped within a pECM hydrogel that mimics the natural pancreatic microenvironment. We show that pECM encapsulation supports the islets' viability and function in culture, and provides temporal protection against cytokine-induced stress. In a diabetic mouse model, pECM encapsulation significantly improved glucose tolerance and achieved glycemic correction without any immunosuppression. These results reveal the potential of pECM encapsulation as a viable treatment for diabetes, providing a solid scientific basis for more advanced preclinical studies.

Detergent-Free Decellularization of the Human Pancreas for Soluble Extracellular Matrix (ECM) Production

Decellularized human pancreatic extracellular matrix-based physiomimetic microenvironment for human islet culture

Extracellular matrix scaffold and hydrogel derived from decellularized and delipidized human pancreas

Which detergent is most suitable for the generation of an acellular pancreas bioscaffold?

In Vitro Expansion of Pancreatic Islet Clusters Facilitated by Hormones and Chemicals.

Culture on a Native Bone Marrow-Derived Extracellular Matrix Restores the Pancreatic Islet Basement Membrane, Preserves Islet Function, and Attenuates Islet Immunogenicity.

Unlocking the Promise of Decellularized Pancreatic Tissue: A Novel Approach to Support Angiogenesis in Engineered Tissue

Establishment of decellularized extracellular matrix scaffold derived from caprine pancreas as a novel alternative template over porcine pancreatic scaffold for prospective biomedical application

ECM-based bioactive microencapsulation significantly improves islet function and graft performance

Construction of engineered 3D islet micro-tissue using porcine decellularized ECM for the treatment of diabetes

3-D physiomimetic extracellular matrix hydrogels provide a supportive microenvironment for rodent and human islet culture

ECM Proteins Nidogen‐1 and Decorin Restore Functionality of Human Islets of Langerhans upon Hypoxic Conditions

Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice

Preparation of Organ Scaffolds by Decellularization of Pancreas and Re-functionalization

Extracellular Matrix Gel is Necessary for in Vitro Cultivation of Insulin Producing Cells from Human Umbilical Cord Blood Derived Mesenchymal Stem Cells

Cardiac-derived extracellular matrix: A decellularization protocol for heart regeneration

Generation of a pancreas derived hydrogel for the culture of hiPSC derived pancreatic endocrine cells

Interpenetrating Network of Alginate–Human Adipose Extracellular Matrix Hydrogel for Islet Cells Encapsulation

Papain-Based Solubilization of Decellularized Extracellular Matrix for the Preparation of Bioactive, Thermosensitive Pregels

Enhancing differentiation and functionality of insulin-producing cells derived from iPSCs using esterified collagen hydrogel for cell therapy in diabetes mellitus

Comparative decellularization and recellularization of normal versus Streptozotocin-induced diabetes mellitus rat pancreas.